In a surprise move, the U.S. Food and Drug Administration reversed course over the weekend and gave emergency use authorization to an antibody treatment for COVID-19.
NEW YORK (CBSNewYork) – In a surprise move, the U. S. Food and Drug Administration reversed course over the weekend and gave emergency use authorization to an antibody treatment for COVID-19. It’s called convalescent plasma, which is taken from recovered COVID patients. In Monday’s Max Minute, CBS2’s Dr. Max Gomez explains what the treatment entails and why many experts are unsure about its safety and efficacy. Plasma is the liquid part of blood. The hope with convalescent plasma is that infusions of antibody-rich plasma can be injected into sick patients, binding or neutralizing the coronavirus so the patients can recover. It’s been given to more than 70,000 COVID-19 patients, with mixed results. MORE: FDA Issues Emergency Authorization For Convalescent Plasma To Be Used As Treatment For COVID-19 Just last week, the FDA declined to issue authorization.
